![Alison Moore](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 693 902 $ al 31/05/2026
En la actualidad, Alison Moore ocupa el cargo de directora técnica de Allogene Therapeutics, Inc. La Dra. Moore también forma parte del consejo de administración de Codexis, Inc. En el pasado, la Dra. Moore ocupó el cargo de Vicepresidenta Senior de Desarrollo de Procesos en Amgen, Inc. y Directora de Química, Fabricación y Controles en Genentech, Inc. Alison Moore se doctoró y se licenció en la Universidad de Manchester.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
CODEXIS, INC. 0,28 % | 20/04/2026 | 250.506 ( 0,28 % ) | 693 902 $ | 31/05/2026 |
| 31/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| CODEXIS, INC. | Director Ejecutivo | 07/11/2025 |
| ARTIVA BIOTHERAPEUTICS, INC. | Director/Miembro de la Junta | 21/10/2024 |
| Empresas | Cargo | Fin |
|---|---|---|
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Director/Miembro de la Junta | 01/10/2023 |
| ALLOGENE THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 28/04/2023 |
| AMGEN INC. | Corporate Officer/Principal | 01/06/2018 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Consejero General | 01/01/2006 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 7 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Codexis, Inc.
 Codexis, Inc. Chemicals: SpecialtyProcess Industries Develops biocatalytic chemical processes | Process Industries |
The University of Manchester
 The University of Manchester Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Health Services |
Allogene Therapeutics, Inc.
 Allogene Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage immuno-oncology | Health Technology |
Artiva Biotherapeutics, Inc.
 Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops natural killer cell-based therapies for patients suffering from autoimmune diseases and cancers | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
